Vitiligo treatment gets positive CHMP opinion
If approved, the JAK inhibitor ruxolitinib cream will be the first repigmentation treatment for non-segmental vitiligo available in the EU.
Stay updated with breaking news from Steven Stein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
If approved, the JAK inhibitor ruxolitinib cream will be the first repigmentation treatment for non-segmental vitiligo available in the EU.
Operator: Hello, and welcome to the Incyte Fourth Quarter and Full Year Financial Results Conference Call and webcast. As a reminder, this conference is being recorded.
Long gone are the days of taking IQ tests. Here's why emotional intelligence is a better predictor of your child’s success.
/PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (Theseus or the Company), a clinical-stage biopharmaceutical company focused on improving the...
California has finally enacted a law, AB195, that provides tax relief for cannabis distributers. But what might seem at first glance to be a win for the cannabis industry potentially...